Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Human Placental Graft in Diabetic Foot Ulcers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients~* 18-80 years old~* Diagnosis of Type 1 or 2 Diabetes Mellitus~* Foot ulcers \>1cm2 and \<25cm2 for 4 weeks or more prior to enrollment~* Able to give consent to participate~* Compliance with all aspects of protocol and follow-up~Exclusion Criteria:~* Male and female patients younger than 18 years old~* Male or female patients older than 80 years old~* Smoking, and any additional health risk factors contraindicated with Revita use~* Involvement in any other ongoing studies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Intervention Treatment (Type: EXPERIMENTAL): Will receive Revita allograft for wound treatment
- Control (Type: NO_INTERVENTION): Will receive current standard of care for wound treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).